INVO Fertility (IVF) Liabilities from Discontinued Operations (2024)
INVO Fertility's (IVF) quarterly Liabilities from Discontinued Operations came in at 284778.0 in Q4 2024.
INVO Fertility (IVF) Liabilities from Discontinued Operations (2024) Analysis & Trends
INVO Fertility (IVF) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 284778.0 in Q4 2024.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 284778.0 in Q4 2024; TTM through Dec 2024 was 284778.0, a N/A change from a year earlier, with the FY2024 full-year figure at 284778.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2024 stood at 284778.0.
- Over the last five years, Liabilities from Discontinued Operations for IVF reached as high as 284778.0 in Q4 2024 and fell as low as 284778.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 284,778.00 |
| Dec 31, 2024 | 284,778.00 |